Modulation of platelet activation by prostaglandin E2 mimics.
Thierauch
K H
KH
Biochemical Pharmacology, Research Laboratories of Schering AG, Berlin, FRG.
Prior
G
G
D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism; D015237:Dinoprost / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors / Q000494:pharmacology; D015232:Dinoprostone / Q000031:analogs & derivatives* / Q000494:pharmacology*; D006801:Humans; D016285:Iloprost / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D015539:Platelet Activation / Q000187:drug effects*; D044006:Receptors, Epoprostenol; D011982:Receptors, Prostaglandin / Q000187:drug effects; D018078:Receptors, Prostaglandin E; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D044006:Receptors, Epoprostenol; D011982:Receptors, Prostaglandin; D018078:Receptors, Prostaglandin E; C061300:ZK 110841; C016767:sulprostone; D015237:Dinoprost; D000242:Cyclic AMP; D016285:Iloprost; D015232:Dinoprostone; D013755:Tetradecanoylphorbol Acetate; D002118:Calcium